TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

NCT04701476 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer; Lung Cancer

Interventions

DRUG: TATE and pembrolizumab
DRUG: TAS-102 pill
DRUG: Regorafenib Pill

Sponsor

Teclison Ltd.

Collaborators

[object Object]